Evidence map›Paper›PMID 29956218›Full record

ArticleDrug safety2018

Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus: A Pharmacoepidemiological-Pharmacodynamic Study in VigiBase

Thi Thu Ha Nguyen, Anne Roussin, Vanessa Rousseau, Jean-Louis Montastruc, François Montastruc

Abstract read
PubMed Publisher
In one paragraph

Article in Drug safety, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Association of first-line antidepressants and incident adverse metabolic effects.Canadian family physician Medecin de famille canadien · 2020
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Thi Thu Ha NguyenService de Pharmacologie Médicale et Clinique, Centre de Pharmacovigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, UMR 1027 INSERM, CIC 1436, Faculté de Médecine, Centre Hospitalier Universitaire, Université Paul Sabatier, 37 allées Jules-Guesde, 31000, Toulouse, France. thi-thu-ha.nguyen1@univ-tlse3.fr.ORCID http://orcid.org/0000-0003-4627-0658
Anne RoussinService de Pharmacologie Médicale et Clinique, Centre de Pharmacovigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, UMR 1027 INSERM, CIC 1436, Faculté de Médecine, Centre Hospitalier Universitaire, Université Paul Sabatier, 37 allées Jules-Guesde, 31000, Toulouse, France.
Vanessa RousseauService de Pharmacologie Médicale et Clinique, Centre de Pharmacovigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, UMR 1027 INSERM, CIC 1436, Faculté de Médecine, Centre Hospitalier Universitaire, Université Paul Sabatier, 37 allées Jules-Guesde, 31000, Toulouse, France.
Jean-Louis MontastrucService de Pharmacologie Médicale et Clinique, Centre de Pharmacovigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, UMR 1027 INSERM, CIC 1436, Faculté de Médecine, Centre Hospitalier Universitaire, Université Paul Sabatier, 37 allées Jules-Guesde, 31000, Toulouse, France.
François MontastrucService de Pharmacologie Médicale et Clinique, Centre de Pharmacovigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, UMR 1027 INSERM, CIC 1436, Faculté de Médecine, Centre Hospitalier Universitaire, Université Paul Sabatier, 37 allées Jules-Guesde, 31000, Toulouse, France.
Université Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe association between antidepressant exposure and type 2 diabetes mellitus is still debated. Moreover, the pharmacological mechanisms remain unknown.

objectiveThe objective of this study was to investigate this putative relationship with the role of antidepressant pharmacological targets using the 'pharmacoepidemiological-pharmacodynamic' method.

methodsFirst, we performed case/non-case analyses in VigiBase

resultsA significant type 2 diabetes signal was found for antidepressants in general, three classes of antidepressants (tricyclic antidepressants, serotonin reuptake inhibitors and "other" antidepressants) and 15 individual antidepressants in particular. Among the antidepressants, three serotonin reuptake inhibitors [escitalopram (adjusted reporting odds ratio 1.15 [1.07-1.25]), paroxetine (1.15 [1.07-1.23]), sertraline (1.23 [1.17-1.31])] and three "other" antidepressants [duloxetine (1.15 [1.07-1.23]), trazodone (1.20 [1.09-1.32]), venlafaxine (1.15 [1.08-1.23])] were the antidepressants most frequently reported with type 2 diabetes. We found a significant correlation between the type 2 diabetes signal and serotonin transporter affinity (slope = 0.14 [0.06-0.23], p = 0.003, R

conclusionThe present study suggests a potential role for serotonin transporter in antidepressant-induced type 2 diabetes.

Indexed as

AdultAgedAntidepressive AgentsCausalityDatabases, FactualDiabetes Mellitus, Type 2FemaleHumansLinear ModelsMaleMiddle AgedPharmacoepidemiologySelective Serotonin Reuptake InhibitorsSerotonin Plasma Membrane Transport ProteinsWorld Health OrganizationAntidepressive AgentsSelective Serotonin Reuptake InhibitorsSerotonin Plasma Membrane Transport Proteins

Identifiers

PMID29956218
OpenAlexW2809911119

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.